On Thursday of last week the FDA approved the first transplant of fetal stem cells into human brains. The first recipients will be children who suffer from a rare and fatal genetic disorder, but if the procedure is successful it could be the first step in making great strides toward treating, curing, and possibly preventing several more common different neurological diseases.
The procedures will be performed by doctors at Stanford University Medical Center on six children suffering from Batten disease. Batten disease is a fatal genetic disease of the nervous system that begins in childhood. The inflicted suffer from visual problems, mental impairment, and seizures, leaving them blind, bedridden, and demented. Most die in their late teens or early twenties.